Mark J. Alles

Insider Reports History

Location
Summit, NJ
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Alles:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC Director Common Stock 15,095 $1,454,856 $96.38 23 May 2023 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 3,666 $16,204 $4.42 16 Sep 2023 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 5,334 $11,841 $2.22 16 Sep 2023 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6,000 01 Jun 2023 Direct
Turning Point Therapeutics, Inc. Director Common Stock 0 $76.00 17 Aug 2022 Direct
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 17 Aug 2022 Direct

Insider Reports Filed by Mark J. Alles

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2023 2 $0 4 Director 19 Sep 2023, 17:47
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2023 2 $0 4 Director 02 Jun 2023, 16:22
BMRN BIOMARIN PHARMACEUTICAL INC 23 May 2023 1 $0 4 Director 24 May 2023, 18:23
BMRN BIOMARIN PHARMACEUTICAL INC 31 Oct 2022 1 +$314,469 4 Director 02 Nov 2022, 18:42
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2022 2 $0 4 Director 19 Sep 2022, 17:08
/report/000120919122046273-alles-mark-j-2022-08-17 Turning Point Therapeutics, Inc. 17 Aug 2022 3 -$152,000 4 Director 17 Aug 2022, 16:32
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 19:06
BMRN BIOMARIN PHARMACEUTICAL INC 24 May 2022 1 $0 4 Director 26 May 2022, 20:12
BMRN BIOMARIN PHARMACEUTICAL INC 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 17:09
BMRN BIOMARIN PHARMACEUTICAL INC 01 Jan 2022 0 $0 3 Director 05 Jan 2022, 13:42
/report/000120919121042325-alles-mark-j-2021-06-21 Turning Point Therapeutics, Inc. 21 Jun 2021 1 +$162,680 4 Director 21 Jun 2021, 21:14
SYRS Syros Pharmaceuticals, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:24
/report/000120919121038329-alles-mark-j-2021-06-02 Turning Point Therapeutics, Inc. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:34
/report/000120919121035956-alles-mark-j-2021-05-24 Turning Point Therapeutics, Inc. 24 May 2021 1 $0 4 Director 26 May 2021, 16:50
/report/000120919121035953-alles-mark-j-2021-05-24 Turning Point Therapeutics, Inc. 24 May 2021 0 $0 3 Director 26 May 2021, 16:46